In agreement with previous reports displaying an EGFR action as a transcription factor [71, 76, 77], ChIP assays revealed that EGFR can be recruited to the AT-rich site located within the promoter sequence of GPER in palbociclib-resistant BC cells. Here, EGFR is linked to breast cancer.